- Home
- BHVN vs EVT Comparison
BHVN vs EVT Comparison
Compare BHVN & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- EVT
- Stock Information
- Founded
- BHVN 2013
- EVT 2003
- Country
- BHVN United States
- EVT United States
- Employees
- BHVN N/A
- EVT N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- BHVN Health Care
- EVT Finance
- Exchange
- BHVN Nasdaq
- EVT Nasdaq
- Market Cap
- BHVN 1.9B
- EVT 1.6B
- IPO Year
- BHVN 2017
- EVT N/A
- Fundamental
- Price
- BHVN $20.24
- EVT $22.79
- Analyst Decision
- BHVN Strong Buy
- EVT
- Analyst Count
- BHVN 14
- EVT 0
- Target Price
- BHVN $62.92
- EVT N/A
- AVG Volume (30 Days)
- BHVN 2.2M
- EVT 143.4K
- Earning Date
- BHVN 05-16-2025
- EVT 01-01-0001
- Dividend Yield
- BHVN N/A
- EVT 8.65%
- EPS Growth
- BHVN N/A
- EVT N/A
- EPS
- BHVN N/A
- EVT 6.63
- Revenue
- BHVN N/A
- EVT $69,404,302.00
- Revenue This Year
- BHVN N/A
- EVT N/A
- Revenue Next Year
- BHVN $65.26
- EVT N/A
- P/E Ratio
- BHVN N/A
- EVT $3.44
- Revenue Growth
- BHVN N/A
- EVT N/A
- 52 Week Low
- BHVN $15.79
- EVT $19.20
- 52 Week High
- BHVN $55.70
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- BHVN 43.79
- EVT 58.14
- Support Level
- BHVN $18.75
- EVT $21.87
- Resistance Level
- BHVN $24.06
- EVT $22.96
- Average True Range (ATR)
- BHVN 2.00
- EVT 0.37
- MACD
- BHVN 0.21
- EVT 0.16
- Stochastic Oscillator
- BHVN 42.39
- EVT 92.13
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.